Articles tagged with Biotechnology Industry
Melissa Cohen, MBA, joins University Hospitals as Vice President of Venture Development and Investment, overseeing investment vehicles, fund strategy, and governance. She brings expertise in health-system venture capital, enterprise transformation, and startup formation to drive innovation and commercialization.
The competition brings seven teams together to pitch optics and photonics technologies with cash prizes and industry mentorship. Previous winners include Max-IR Labs, Advanced Optronics, and Coalesenz.
The new integrations provide enterprise AI agents direct access to live, structured research data from Dimensions' 430M+ interconnected records. This allows for AI-assisted analytics across one of the world's most comprehensive linked views of global research activity.
The US retains its scientific edge but is losing the race to translate discoveries into cures, warns a new report from Cure Innovation Index. Without immediate renewed investment and policy changes, the US scientific edge will not hold.
Compass combines Dimensions citation data and Altmetric attention metrics in a single platform, providing real-time publication intelligence. This solution addresses the fragmented data challenge faced by medical affairs teams, enabling them to make informed strategic decisions and communicate impact more effectively.
OYE-101, a novel intravenous caffeine formulation, has been developed to accelerate recovery from general anesthesia and deep sedation. The company's lead program is being evaluated in a scientific bridging study to support a 505(b)(2) NDA for OYE-101.
The study found that the extract reduced cell damage compounds by over 75% and preserved skin health with over 60% of cells remaining alive. The researchers developed a natural dye, produced by Talaromyces amestolkiae fungus, which can be used in cosmetic formulations while maintaining safety and functionality.
A team from Universitat Jaume I creates a biostimulant composition using proline particles encapsulated in silica, enhancing plant tolerance to drought, high temperatures and salinity. The new compound's production process is scalable, cost-effective and reproducible, with potential for industrial-level application.
A new study by Binghamton University School of Management reveals that businesses can improve their performance when they openly discuss and address cybersecurity issues. The research found a positive correlation between cybersecurity readiness and firm performance, suggesting that proactive measures can lead to better outcomes.
Phyton Biotech has successfully transferred the manufacturing process for Corallopyronin A (CorA), a novel anti-infective agent with potent activity against filarial infections and bacterial infections. The technology transfer marks an important milestone in the Company's specialty GMP fermentation capabilities.
The University of Texas at Arlington and TEES launched a new biomanufacturing training and research hub in Dallas, providing hands-on training and state-of-the-art lab space. The National Center for Therapeutics Manufacturing satellite campus strengthens North Texas' biotech workforce and expands research opportunities.
A study identified 167 native species of the Atlantic Forest with bioeconomic applications, including medical, cosmetic, and food sectors. The researchers found that 78 species have registered patents in 61 countries, offering an economic incentive for reforestation projects.
The article highlights the mismatch between psychedelics and economic drug development principles. Pharmaceutical companies are developing short-acting compounds and neuroplastogens to engineer trips out of the experience altogether. Dr. Sandy Hager's research suggests investors should remain cautious due to weak intellectual property ...
Insilico Medicine's founder Alex Zhavoronkov, PhD, is named among 100 global leaders driving the future of artificial intelligence. The company has developed breakthrough solutions for novel target discovery and drug development using generative AI.
Researchers at North Carolina State University have developed a controlled evolution technique that dramatically increases plasmid DNA (pDNA) production in E. coli bacteria. This breakthrough could significantly reduce the cost of gene therapies and expedite research, making pDNA resources more accessible.
The collaboration aims to bridge academia and industry through joint research projects, academic exchange, and hands-on training for students and faculty. The partnership also opens career opportunities for UAEU graduates at Insilico, fostering local talent and supporting the expansion of the UAE's biotechnology sector.
Researchers discovered how certain bacteria breathe by generating electricity, using a natural process that pushes electrons into their surroundings. This finding could enable new developments in clean energy and industrial biotechnology.
The RFS Awards in Science 2024 recognize outstanding peer-reviewed research by women and underrepresented minorities in STEM. The awards honor the best papers written in 2024, with winners receiving a $1,000 cash prize and free access to their publications for 90 days.
Dr. Gadhamshetty, a leading expert in environmental engineering, brings over 25 years of experience to the role. He aims to expand the journal's influence and promote transformative research that addresses critical environmental challenges.
This study analyzed changes in bacterial and fungal communities in the rhizosphere soil around GG2 treated with glyphosate, revealing temporary effects on diversity and richness. The integration of transgenic genes had no impact on microbial diversity, while seasonal changes and soil indices such as pH and organic matter significantly ...
Simon Fraser University has received a $23 million grant to expand its Invention to Innovation (i2I) programs, providing bilingual innovation and entrepreneurship training for graduate students, researchers, and faculty. The program aims to bridge the gap between invention and innovation, equipping researchers with skills to thrive as ...
Researchers synthesizing AI with biomarker analysis aim to detect early signs of aging and enable targeted interventions to delay disease. This approach has the potential to slow, prevent or reverse certain effects of aging.
Research from Bentley University shows that biotechnology companies can maintain current levels of new drug approvals in face of global revenue reductions. Strategic distribution of cost reductions and continued investment in early-stage development by biotech firms sustain pipeline, contradicting industry claims.
Researchers isolated three bacterial strains that produce amylase enzymes from sugar factory waste, showing great potential for production. The optimal conditions for amylase production were found to be 37°C and pH 7.0, leading to increased enzyme activity.
Researchers at ETH Zurich have developed a new method to produce chemicals using bacteria that feed on methanol, a renewable resource. The microbes can efficiently convert methanol into desired biochemical substances, offering a sustainable alternative to fossil-based chemicals.
A research team at KTH Royal Institute of Technology developed a simple technique for fabricating electrochemical transistors using standard 3D microprinters, enabling fast prototyping and scaling of bioelectronic devices. The method replaces time-consuming processes requiring expensive cleanroom environments.
Researchers at the University of Manchester have developed a new genetic biocontainment method that directly targets essential proteins, providing a robust escape frequency. The method uses an estradiol-controlled destabilizing domain degron to control survival of genetically engineered yeast organisms.
Researchers at Delft University of Technology have developed pioneering advancements in the purification of isopropanol and acetone from waste gases through engineered bacteria. The novel process shows high-purity yields with recoveries over 99.2%, marking a significant step forward in sustainable industrial fermentation.
Researchers establish new standards for laboratory experiments to improve PET recycling efficiency. Four engineered enzymes were tested, with LCC-ICCG outperforming the others in terms of depolymerisation rate and enzyme requirement. The study aims to accelerate the development of industrial-scale solutions for PET waste management.
The University of Missouri is launching a five-year, $3 million doctoral training program to prepare the next generation of scientists and engineers for emerging fields like materials science and data science. The program aims to empower future workers with both technical expertise and data-driven insights.
A review article proposes zero-waste methodologies to convert 100% of marine macroalgae (seaweed) into cosmetics ingredients using industrially available green technology. This enables the cosmetics industry to meet environmental sustainability and ESG requirements, while leveraging the potential of Brazilian seaweed.
A new partnership between Patrick Reed and Kenneth Eilertsen is putting a focus on translational research and commercialization at Pennington Biomedical. The team aims to evaluate patentability and marketability of potential disclosures, promoting public benefit from scientific discoveries.
A new review paper highlights the potential of fungal biotechnology to advance various industries. By manipulating fungal genomes, researchers can develop bioinformatic tools and create sustainable biomaterials, such as machine learning algorithms for predicting mycological patterns or fungal batteries.
A recent study published in PLOS ONE found that academic institutions receive significantly lower royalty rates, total payments, and pre-commercial payments for biotechnology licenses compared to commercial firms. The disparities were observed even after accounting for differences in product stage development.
The latest issue of PLOS Biology features a special collection on biology-based solutions to reduce plastic pollution, carbon dioxide emissions, and produce food or energy more sustainably. Insect enzymes may degrade plastic waste, while photosynthetic algae can capture CO2 produced by industrial applications.
The five finalists of the Bright SCIdea Challenge will compete for a £5,000 prize by pitching their scientific business ideas that could benefit society. The project ideas include burn treatments and environmental calculators.
Researchers have developed a method that uses urea from urine to trigger the production of proteins in bacteria, replacing costly 'inducer' molecules. The new system produces similar quantities of protein as standard methods while being cheaper and easier to use, opening up new avenues for biotech industries.
Researchers at KAUST have identified thermophilic bacteria with potential to degrade oil contamination. The study reveals that certain bacteria can secrete surfactants and absorb emulsified petroleum into their cells for degradation via enzymatic activity.
A team of researchers from the University of Cologne identified a possible key enzyme that enables algae-eating protists to dissolve algal cell walls. The study, published in Current Biology, reveals new insights into the molecular toolkit used by these organisms to interact with their prey.
Researchers at DTU Compute and DIKU have developed a machine learning model that can map the potential of proteins, enabling the biotech industry to accelerate the development of new proteins. The model generates a picture of how proteins are linked, allowing for the identification of closely related proteins with desirable properties.
A team of biochemists at the University of Groningen discovered that membrane thickness, lipid phase, and sterol type are key factors in determining permeability. This knowledge can help companies optimize microbial production and improve drug design.
Scientists from Karlsruhe Institute of Technology (KIT) have successfully embedded enzymes in metal-organic frameworks to enhance their stability. This innovation enables the use of these enzymes in both aqueous and organic solvents, leading to improved productivity and stability in continuous reactors.
Researchers at TUM have successfully produced succinic acid using the marine bacterium Vibrio natriegens, which has rapid growth and substrate uptake rates. The team is now working to optimize the process for industrial-scale production using renewable raw materials.
Roswell Biotechnologies has developed a molecular electronics sensor on a semiconductor chip, enabling real-time detection of single molecules for diverse applications including drug discovery, diagnostics, and DNA sequencing. The platform offers unlimited scalability in sensor pixel density and high resolution measurements.
A new study found that a subtilisin-like proteinase from Bacillus pumilus 3-19 exhibits proteolytic activity in Pichia pastoris, dependent on incubation time and signal peptide choice. The production of this enzyme makes the system promising for developing new feed additives for animal husbandry.
Researchers at the Chinese Academy of Sciences have developed a chemoenzymatic system that converts CO2 into starch with an efficiency 8.5-fold higher than natural biosynthesis. This innovative technology has the potential to produce starch from CO2 on a large scale, reducing the need for cultivated land and freshwater resources.
Scientists from Nara Institute of Science and Technology have created a simple and fast method for detecting cell shape as they pass through a microfluidic channel. The team used changes in electrical impedance to measure the asymmetry of individual cells, which may greatly accelerate biological experiments.
Companies are pivoting to biotechnology to manufacture scents and flavors using fermented microbes, which are more sustainable than traditional methods. This approach allows for the creation of new fragrance molecules with consistent flavor and smell, meeting consumer demand and reducing environmental impact.
A new study from Bentley University finds that emerging public biotech companies generated over $100 billion in shareholder value despite a high failure rate. The research compares the financial performance of biotech and non-biotech companies with similar IPO timelines, revealing comparable success rates and economic value creation.
Researchers at Graz University of Technology and Austrian Centre of Industrial Biotechnology have discovered the mechanism behind Apiose production, a key factor in plant robustness. The enzyme UAXS selectively catalyzes four reaction steps, enabling plants to build strength properties.
Researchers found that certain transporter proteins, such as MAE1 from Schizosaccharomyces pombe, can improve the secretion of dicarboxylic acids in baker's yeast with minimal energy expenditure. Building a comprehensive library of transporters will enable more efficient strain development and precise drug development.
The Science/Science Careers' 2017 Top Employers Survey ranked Regeneron the top biopharmaceutical employer, followed by Biogen and Pfizer. The survey received over 6,950 responses from employees in biotechnology, biopharmaceutical, and pharmaceutical companies worldwide.
MIT Portugal's International Industry Roundtable on new technologies for old industries brought together industry leaders to discuss common objectives and share innovative ideas. The roundtable aimed to bridge the gap between academia and industry in sectors such as agriculture and energy.
Professor Tyagi received the Outstanding Scientist Award from the International Bioprocessing Association for his outstanding contribution to environmental biotechnology. He has also earned numerous accolades, including awards from the American Academy of Environmental Engineers and Scientists.
The European Summit of Industrial Biotechnology 2016 highlights the growing importance of biotech, with a focus on innovative technologies like CRISPR/CAS and automated lab systems. However, severe challenges are emerging, including the potential automation of labs and the decline of human roles in scientific research.
Research and patents in biotechnology are increasing steadily across the developing world, with international collaborations playing a key role. The report highlights the growth of biotech papers from sub-Saharan Africa, particularly in infectious diseases research.
Researchers have discovered a way to custom-build valuable triterpenes using 'chemical origami', a process inspired by the ancient Japanese art of origami. By modifying an enzyme called SAD1, they can produce different triterpene scaffolds and building blocks, leading to new medicines and industrial chemicals.
The UPSC Berzelii Centre at Umea University has been granted a five-year extension of funding as a Vinnova Competence Centre. The centre's research groups have successfully collaborated with industrial partners to translate basic research into applications in the Swedish forest industry.
Fifty NSF-funded biotech companies will exhibit innovative products and processes, including diagnostics and monitoring technologies, drug discovery platforms, and engineering biology innovations. These early-stage companies have the potential to transform the US healthcare system with novel high-tech solutions.
The Werner Siemens Foundation has donated 11.5 million euros to support the launch of Synthetic Biotechnology at the Technical University of Munich (TUM). This new focus integrates research approaches from biochemistry, bioinformatics, and industrial biotechnology.